Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach

Author： Sugarbaker Paul H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.12, 2009-08, pp. : 1965-1977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Point: Intraperitoneal Chemotherapy in the Management of Ovarian Cancer

By Markman Maurie  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 549-554

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy

By  

Current Drug Discovery Technologies, Vol. 6, Iss. 1, 2009-03 ,pp. : 72-81

Bentham Science Publishers

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-05 ,pp. : 511-519

Bentham Science Publishers

Access to resources Recommend Favorite

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3793-3803

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Cytoreductive/Debulking Surgery in Ovarian Cancer

By Wakabayashi Mark T.   Lin Paul S.   Hakim Amy A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 8, 2008-09 ,pp. : 803-811

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite